Feedback from the public

ESR

2.7.1.3. The specific considerations of procurement of medications and medical devices necessitated by the pandemic or carried out during the pandemic are established in such a way as to prevent corruption risks

Problem solving:

2.7.1. Patients and doctors do not receive medications and medical devices in a timely manner and in full, in particular due to the incomplete transition to the new system of organization and control of medical procurement, and the incomplete regulation of the processes of identifying the needs for and accounting of medications

Deadlines for all measures within ESR

01.03.2023 - 31.10.2023

Implementation of SACP measures within ESR

Total number of measures – 5

4 1

Implemented Partially implemented

Implementation of SACP measures within the scope of the Problem by main main performers

Ministry of Health of Ukraine

100%

Summarized general information on Measures

№	Name of the measure	The main implementer	Co-implementors	Performance indicator	Monitoring results (latest)	Статус
1	2.7.1.3.1 Arranging an analytical study on the assessment of corruption risks in the procurement of medications and medical devices necessitated by the pandemic or conducted during the pandemic, with the presentation of statistical, economic, and other data, as well as the relevant proposals on how to prevent the identified corruption risks and to enhance the transparency and effectiveness of the procurement procedures in question	Ministry of Health of Ukraine	Національне агентство з питань запобігання корупції	The analytical study has been conducted and a report on its findings has been published.	The measure was implemented on time and in full	Implemented
2	2.7.1.3.2 Holding a presentation of the report on the findings of the analytical study indicated in subclause 2.7.1.3.1, followed by its discussion with stakeholders	Ministry of Health of Ukraine	Національне агентство з питань запобігання корупції	The discussion has been conducted and its results have been publicized.	The measure was implemented on time, but partially	Partially implemented
3	2.7.1.3.3 Drafting normative legal acts on amendments to normative legal acts, taking into account the findings of the analytical study indicated in subclause 2.7.1.3.1 (if needed)	Ministry of Health of Ukraine		The draft normative legal acts have been publicized for a public discussion.	The measure was implemented on time and in full	Implemented
4	2.7.1.3.4 Holding a public discussion of the draft normative legal acts indicated in subclause 2.7.1.3.3 (if needed)	Ministry of Health of Ukraine		The public discussion has been conducted and its results have been made public.	The measure was implemented on time and in full	Implemented
5	2.7.1.3.5 Final revision (if needed) and approval of the draft normative legal acts indicated in subclause 2.7.1.3.3 (if needed)	Ministry of Health of Ukraine		The amendments to the normative legal acts have been approved.	The measure was implemented on time and in full	Implemented

Indicators of achievement of ESR

Total number of indicators – 2

Indicators fully achieved – 1

Partially achieved indicators – 0

Indicators with a score of 0% – 1

Оцінка досягнення ОСР - 90%

Рівень досягнення ОСР - високий

Summarized general information about Achievement Indicators

* - Вага - програмне значення індикатора в ОСР

№	Indicators	Weight* (%)	Assessment of achievement		Evaluation rationale	Data source/information manager
№	Indicators	Weight* (%)	for the year 2024	for the year 2025	Evaluation rationale	Data source/information manager
1	An analytical report has been published on the findings of the analytical study on the assessment of corruption risks in the procurement of medications and medical devices necessitated by the pandemic or conducted during the pandemic, with the presentation of proposals on how to prevent the identified corruption risks and to enhance the transparency and effectiveness of the procurement procedures.	90%	90%		За результатами проведення І циклу поточної (щорічної) оцінки ефективності реалізації Антикорупційної стратегії на 2021-2025 роки та Державної антикорупційної програми на 2023-2025 роки встановлено, що індикатор 1 очікуваного стратегічного результату 2.7.1.3. досягнуто повністю з огляду на те, що оприлюднено аналітичний звіт за результатами оцінки корупційних ризиків під час закупівель лікарських ... ->	Official website of the Ministry of Health
2	Amendments to normative legal acts have come into force, which pertain to the specific considerations of procurement of medications and medical devices necessitated by the pandemic or carried out during the pandemic, taking into account the findings of the analytical study indicated in subclause 1 of clause 2.7.1.3.	10%	0%		За результатами проведення І циклу поточної (щорічної) оцінки ефективності реалізації Антикорупційної стратегії на 2021-2025 роки та Державної антикорупційної програми на 2023-2025 роки встановлено, що індикатор 2 очікуваного стратегічного результату 2.7.1.3 не досягнуто з огляду на те, що зміни до нормативно-правових актів, які стосується особливостей закупівель лікарських засобів та медичних ви... ->	Official printed publications Official website of the Cabinet of Ministers of Ukraine Unified State Register of Normative Legal Acts

Key sources of assessment:

1. Міністерство охорони здоров'я України: ОСР 2.7.1.3., індикатор № 1 Аналітичний звіт щодо оцінки корупційних ризиків під час закупівель лікарських засобів та медичних виробів.

ESR